Skip to main content
. 2020 May 22;10(4):707–720. doi: 10.1007/s13555-020-00397-5

Table 1.

Demographic data of onaA-tolerant patients

Group Median age (years) Gender Median duration (years) Median dose/visit (units) Median number of injections Median interval (months) Median total dose (units)
Female, n (%) Male, n (%)
All 34 25 (73.5) 9 (26.5)
IncoA-responsive patients (n = 7) 35 6 (85.70) 1 (14.30) 7 70 12 5 800
IncoA-tolerant patients (n = 15) 33 14 (03.30) 1 (6.70) 7 100 16 5 1600
p value 0.731 0.07 < 0.05 0.267 < 0.01